Articles related to LONG-TERM CARE (LTC)
Psychological Dimensions of Palliative Care Consultation: Approaches to Seriously Ill Patients at the End of Life
There is plenty of psychological material that can be examined in the palliative care encounter, despite the fact that it is frequently practiced by doctors with backgrounds outside of mental health training. This case presentation and associated discussion to introduce the psychological aspects of palliative medicine to psychiatrists and psychotherapists is based on the palliative care consultation sought with the multiple objectives of alleviating a patient’s severe death anxiety and persistent dyspnea, as well as helping in the clarification of his end-of-life wishes.
Geriatrics August 22nd 2022
Overall Survival Remains Important in Trials of Early-Line Multiple Myeloma Therapy
In an editorial accompanying the final results of the TOURMALINE-MM1 study, Drs. D’Souza and Lonial question whether overall survival (OS) is “still the gold standard for demonstrating the value of a novel agent in phase III trials early in the disease course given the current treatment landscape.”
Hematology/Oncology March 29th 2022
Risks of Mental Health Outcomes in People with COVID-19: Cohort Study
The British Medical Journal reports that people who survive COVID-19 are at increased risk of an array of mental health disorders, including anxiety, depression, and opioid use disorder, cognitive decline, sleep disorders, and more. The authors recommend close monitoring of patients following infection and up-prioritizing managing their mental health disorders.
Allergy & Immunology March 1st 2022
Comparative Fracture Risk During Osteoporosis Drug Holidays After Long-Term Risedronate vs. Alendronate Therapy
A new study has found that people with osteoporosis may experience less protection and be subject to more bone fractures when treated with the drug risedronate. Patients who were treated with risedronate during a drug holiday experienced more hip and other fractures than patients given other medications. Drug holidays are recommended after three to five years on therapy for most people taking bisphosphonates for osteoporosis. Risedronate, with its shorter half-life compared with alendronate, is associated with a somewhat higher risk of hip fracture during a drug holiday.
Endocrinology, Diabetes, Metabolism January 19th 2022
Questioning Aspirin’s Role After Percutaneous Coronary Intervention and Acute Coronary Syndrome
Most current guidelines recommend at least 12 months of dual anti-platelet therapy for ACS and post PCI. But is that the best approach in an aging population with inherent higher bleeding risk? Some are advocating very early cessation of aspirin as well as scaling down the P2Y12 inhibitor in the first few months post event.
Cardiology January 5th 2022
Living With COVID: A Long Hauler’s Journey
Amy Watson became famous for coining the term “COVID long hauler” to describe people, such as herself, who suffer from the effects of the respiratory disease over an extended period. These long-haul symptoms can include fever, body aches, and fatigue. Watson herself says she rarely goes more than a few hours without suffering a fever, nearly two years after first contracting COVID-19. GoodRx Health chronicles Amy Watson’s story and what it’s like for people suffering from long COVID.
Allergy & Immunology December 14th 2021